Profile | GDS5420 / 220765_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 148.48 | 48 |
GSM1296119 | B_lesional_pre-dose | 80 | 36 |
GSM1296076 | C_lesional_pre-dose | 121.41 | 46 |
GSM1296092 | D_lesional_pre-dose | 48.61 | 33 |
GSM1296103 | E_lesional_pre-dose | 93.99 | 41 |
GSM1296078 | F_lesional_pre-dose | 103.61 | 43 |
GSM1296107 | G_lesional_pre-dose | 159.85 | 48 |
GSM1296109 | H_lesional_pre-dose | 205.89 | 52 |
GSM1296080 | I_lesional_pre-dose | 230.12 | 55 |
GSM1296090 | J_lesional_pre-dose | 99.37 | 43 |
GSM1296074 | K_lesional_pre-dose | 77.22 | 40 |
GSM1296111 | L_lesional_pre-dose | 127.33 | 43 |
GSM1296099 | M_lesional_pre-dose | 189.71 | 51 |
GSM1296086 | O_lesional_pre-dose | 61.83 | 35 |
GSM1296117 | P_lesional_pre-dose | 149.95 | 46 |
GSM1296113 | Q_lesional_pre-dose | 231.14 | 53 |
GSM1296096 | R_lesional_pre-dose | 147.59 | 48 |
GSM1296105 | S_lesional_pre-dose | 329.32 | 60 |
GSM1296098 | T_lesional_pre-dose | 170.46 | 49 |
GSM1296101 | U_lesional_pre-dose | 156.83 | 48 |
GSM1296121 | V_lesional_pre-dose | 90.79 | 39 |
GSM1296088 | W_lesional_pre-dose | 81.12 | 39 |
GSM1296082 | X_lesional_pre-dose | 55.42 | 34 |
GSM1296115 | Y_lesional_pre-dose | 123.77 | 44 |
GSM1296084 | Z_lesional_pre-dose | 161.44 | 49 |
GSM1296072 | B_lesional_day8 | 95.26 | 39 |
GSM1296069 | L_lesional_day8 | 174.59 | 48 |
GSM1296071 | P_lesional_day8 | 232.09 | 53 |
GSM1296070 | Y_lesional_day8 | 159.9 | 47 |
GSM1296073 | V_lesional_day8 | 90.69 | 39 |
GSM1296034 | A_lesional_day15 | 490.76 | 66 |
GSM1296041 | G_lesional_day15 | 105.52 | 41 |
GSM1296035 | R_lesional_day15 | 144.72 | 48 |
GSM1296038 | U_lesional_day15 | 189.68 | 52 |
GSM1296047 | B_lesional_day15 | 163.83 | 48 |
GSM1296039 | E_lesional_day15 | 83.86 | 39 |
GSM1296042 | H_lesional_day15 | 177.31 | 49 |
GSM1296043 | L_lesional_day15 | 246.88 | 54 |
GSM1296037 | M_lesional_day15 | 548.46 | 69 |
GSM1296046 | P_lesional_day15 | 108.93 | 40 |
GSM1296044 | Q_lesional_day15 | 205.69 | 51 |
GSM1296045 | Y_lesional_day15 | 194.17 | 50 |
GSM1296025 | C_lesional_day15 | 445.32 | 66 |
GSM1296033 | D_lesional_day15 | 149.41 | 48 |
GSM1296027 | I_lesional_day15 | 364.17 | 63 |
GSM1296032 | J_lesional_day15 | 258.17 | 56 |
GSM1296024 | K_lesional_day15 | 356.11 | 62 |
GSM1296031 | W_lesional_day15 | 283.46 | 57 |
GSM1296028 | X_lesional_day15 | 243.74 | 56 |
GSM1296029 | Z_lesional_day15 | 325.55 | 60 |
GSM1296026 | F_lesional_day15 | 209.15 | 54 |
GSM1296030 | O_lesional_day15 | 174.53 | 52 |
GSM1296040 | S_lesional_day15 | 382.1 | 63 |
GSM1296036 | T_lesional_day15 | 126.22 | 44 |
GSM1296048 | V_lesional_day15 | 92.83 | 39 |
GSM1296059 | A_lesional_day43 | 214.48 | 54 |
GSM1296066 | G_lesional_day43 | 156.32 | 47 |
GSM1296060 | R_lesional_day43 | 162.14 | 49 |
GSM1296063 | U_lesional_day43 | 139.08 | 46 |
GSM1296064 | E_lesional_day43 | 75.17 | 38 |
GSM1296067 | H_lesional_day43 | 279.07 | 56 |
GSM1296062 | M_lesional_day43 | 268.76 | 57 |
GSM1296068 | Q_lesional_day43 | 217.47 | 52 |
GSM1296050 | C_lesional_day43 | 264.51 | 57 |
GSM1296057 | D_lesional_day43 | 242.48 | 55 |
GSM1296052 | I_lesional_day43 | 293.83 | 60 |
GSM1296054 | J_lesional_day43 | 273.88 | 57 |
GSM1296049 | K_lesional_day43 | 250.55 | 56 |
GSM1296055 | W_lesional_day43 | 372.68 | 62 |
GSM1296053 | X_lesional_day43 | 349.9 | 61 |
GSM1296058 | Z_lesional_day43 | 422.1 | 65 |
GSM1296051 | F_lesional_day43 | 135.44 | 47 |
GSM1296056 | O_lesional_day43 | 137.21 | 48 |
GSM1296065 | S_lesional_day43 | 168.37 | 49 |
GSM1296061 | T_lesional_day43 | 254.25 | 56 |
GSM1296095 | A_non-lesional_pre-dose | 144 | 48 |
GSM1296120 | B_non-lesional_pre-dose | 114.48 | 42 |
GSM1296077 | C_non-lesional_pre-dose | 340.22 | 62 |
GSM1296093 | D_non-lesional_pre-dose | 243.32 | 55 |
GSM1296104 | E_non-lesional_pre-dose | 158.93 | 49 |
GSM1296079 | F_non-lesional_pre-dose | 291.92 | 59 |
GSM1296108 | G_non-lesional_pre-dose | 199.81 | 51 |
GSM1296110 | H_non-lesional_pre-dose | 212.79 | 51 |
GSM1296081 | I_non-lesional_pre-dose | 435.85 | 66 |
GSM1296091 | J_non-lesional_pre-dose | 142.08 | 48 |
GSM1296075 | K_non-lesional_pre-dose | 195.21 | 53 |
GSM1296112 | L_non-lesional_pre-dose | 277.5 | 56 |
GSM1296100 | M_non-lesional_pre-dose | 602.43 | 70 |
GSM1296087 | O_non-lesional_pre-dose | 299.21 | 60 |
GSM1296118 | P_non-lesional_pre-dose | 169.19 | 48 |
GSM1296114 | Q_non-lesional_pre-dose | 228.5 | 53 |
GSM1296097 | R_non-lesional_pre-dose | 261.82 | 57 |
GSM1296106 | S_non-lesional_pre-dose | 232.27 | 54 |
GSM1296102 | U_non-lesional_pre-dose | 360.84 | 61 |
GSM1296122 | V_non-lesional_pre-dose | 292.76 | 58 |
GSM1296089 | W_non-lesional_pre-dose | 282.82 | 57 |
GSM1296083 | X_non-lesional_pre-dose | 450.1 | 65 |
GSM1296116 | Y_non-lesional_pre-dose | 159.7 | 46 |
GSM1296085 | Z_non-lesional_pre-dose | 323.66 | 60 |